The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene label mismatch: LDLR vs undefined
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000527.5(LDLR):c.91G>A (p.Glu31Lys)

CA041752

251013 (ClinVar)

Gene: LDLR
Condition: hypercholesterolemia, familial
Inheritance Mode: Semidominant inheritance
UUID: 47029d08-db26-42fe-bf8b-bcd8c066753d
Approved on: 2023-03-24
Published on: 2025-04-23

HGVS expressions

NM_000527.5:c.91G>A
NM_000527.5(LDLR):c.91G>A (p.Glu31Lys)
NC_000019.10:g.11100246G>A
CM000681.2:g.11100246G>A
NC_000019.9:g.11210922G>A
CM000681.1:g.11210922G>A
NC_000019.8:g.11071922G>A
NG_009060.1:g.15866G>A
ENST00000252444.10:c.349G>A
ENST00000559340.2:c.91G>A
ENST00000560467.2:c.91G>A
ENST00000558518.6:c.91G>A
ENST00000252444.9:c.345G>A
ENST00000455727.6:c.91G>A
ENST00000535915.5:c.91G>A
ENST00000545707.5:c.91G>A
ENST00000557933.5:c.91G>A
ENST00000557958.1:n.177G>A
ENST00000558013.5:c.91G>A
ENST00000558518.5:c.91G>A
ENST00000560502.5:n.177G>A
NM_000527.4:c.91G>A
NM_001195798.1:c.91G>A
NM_001195799.1:c.91G>A
NM_001195800.1:c.91G>A
NM_001195803.1:c.91G>A
NM_001195798.2:c.91G>A
NM_001195799.2:c.91G>A
NM_001195800.2:c.91G>A
NM_001195803.2:c.91G>A
More

Uncertain Significance

Met criteria codes 2
PM2 PP3
Not Met criteria codes 23
PVS1 BA1 PM6 PM3 PM1 PM4 PM5 BS4 BS3 BS1 BS2 BP7 BP2 BP3 BP4 BP1 PS2 PS4 PS3 PS1 PP4 PP1 PP2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Familial Hypercholesterolemia Expert Panel Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Familial Hypercholesterolemia VCEP
The NM_000527.5(LDLR):c.91G>A (p.Glu31Lys) variant is classified as Uncertain significance - insufficient evidence for Familial Hypercholesterolemia by applying ACMG/AMP evidence codes PM2 and PP3 as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (specification version 1.2) on 24 March 2023. The supporting evidence is as follows: PM2: PopMax MAF = 0.00005 (0.005%) in European (Non-Finnish) exomes (gnomAD v2.1.1). PP3: REVEL = 0.777.
Met criteria codes
PM2
PopMax MAF = 0.00005 (0.005%) in European (Non-Finnish) exomes (gnomAD v 2.1.1).
PP3
REVEL = 0.777, this is greater than 0.75.
Not Met criteria codes
PVS1
Not a null variant.
BA1
Not met.
PM6
Not met.
PM3
Not met.
PM1
Not located in exon 4.
PM4
Not an in-frame insertion/deletion.
PM5
Not met.
BS4
Not met.
BS3
Not met.
BS1
Not met.
BS2
Not met.
BP7
Not a synonymous variant.
BP2
Not met.
BP3
Not applicable
BP4
REVEL = 0.777
BP1
Not applicable
PS2
Not met.
PS4
Variant has been described in several publications (PMID 20145306, 34428338, 35910211), however, clinical criteria not met for identified probands.
PS3
Not met.
PS1
Not met.
PP4
Clinical criterial not met on patients.
PP1
Not met.
PP2
Not applicable
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.